206. 脆弱X症候群 Fragile X syndrome Clinical trials / Disease details


臨床試験数 : 108 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05367960
(ClinicalTrials.gov)
November 1, 202229/4/2022An Open-Label Extension Study of BPN14770 in Subjects With Fragile X SyndromeAn Open-Label Extension Study of BPN14770 in Subjects With Fragile X SyndromeFragile X SyndromeDrug: Zatolmilast/ BPN14770Tetra Discovery PartnersNULLEnrolling by invitation12 Years45 YearsMale300Phase 3United States